NASDAQ:HCAT - Health Catalyst Stock Price, News & Analysis

$38.63
-4.31 (-10.04 %)
(As of 08/25/2019 03:24 AM ET)
Today's Range
$38.62
Now: $38.63
$42.4750
50-Day Range N/A
52-Week Range
$36.29
Now: $38.63
$49.85
Volume964,724 shs
Average Volume792,086 shs
Market Capitalization$1.36 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. The company is headquartered in Salt Lake City, Utah.

Industry, Sector and Symbol

Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HCAT
CUSIPN/A
CIKN/A
Phone801-708-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees728
Market Cap$1.36 billion
Next Earnings Date11/28/2019 (Estimated)
OptionableNot Optionable

Receive HCAT News and Ratings via Email

Sign-up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.


Health Catalyst (NASDAQ:HCAT) Frequently Asked Questions

What is Health Catalyst's stock symbol?

Health Catalyst trades on the NASDAQ under the ticker symbol "HCAT."

How were Health Catalyst's earnings last quarter?

Health Catalyst (NASDAQ:HCAT) posted its earnings results on Thursday, August, 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.34) by $0.13. The firm earned $36.80 million during the quarter, compared to analyst estimates of $36.44 million. The company's revenue was up 60.1% on a year-over-year basis. View Health Catalyst's Earnings History.

When is Health Catalyst's next earnings date?

Health Catalyst is scheduled to release their next quarterly earnings announcement on Thursday, November 28th 2019. View Earnings Estimates for Health Catalyst.

What price target have analysts set for HCAT?

8 brokers have issued 12-month price objectives for Health Catalyst's shares. Their predictions range from $47.00 to $55.00. On average, they anticipate Health Catalyst's stock price to reach $51.2857 in the next year. This suggests a possible upside of 32.8% from the stock's current price. View Analyst Price Targets for Health Catalyst.

What is the consensus analysts' recommendation for Health Catalyst?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Health Catalyst.

Has Health Catalyst been receiving favorable news coverage?

News stories about HCAT stock have been trending positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Health Catalyst earned a daily sentiment score of 2.5 on InfoTrie's scale. They also gave news stories about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the next several days. View News Stories for Health Catalyst.

Who are some of Health Catalyst's key competitors?

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include Coupa Software (COUP), Cronos Group (CRON), Immunomedics (IMMU), Pure Storage (PSTG), PVH (PVH), Teck Resources (TECK), Autodesk (ADSK), Ability (ABIL), Axon Enterprise (AAXN) and American Airlines Group (AAL).

Who are Health Catalyst's key executives?

Health Catalyst's management team includes the folowing people:
  • Mr. Daniel D. Burton, CEO & Director (Age 44)
  • Mr. J. Patrick Nelli Jr., Chief Financial Officer
  • Mr. Dale Sanders, Chief Technology Officer (Age 59)
  • Mr. Steven C. Barlow, Co-Founder & Sr. VP (Leave of Absence)
  • Mr. Thomas D. Burton, Co-Founder & Pres of Professional Services

When did Health Catalyst IPO?

(HCAT) raised $129 million in an initial public offering on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

When does Health Catalyst's quiet period expire?

Health Catalyst's quiet period expires on Tuesday, September 3rd. Health Catalyst had issued 7,000,000 shares in its IPO on July 25th. The total size of the offering was $182,000,000 based on an initial share price of $26.00. During Health Catalyst's quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Health Catalyst?

Shares of HCAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Health Catalyst's stock price today?

One share of HCAT stock can currently be purchased for approximately $38.63.

How big of a company is Health Catalyst?

Health Catalyst has a market capitalization of $1.36 billion. Health Catalyst employs 728 workers across the globe.View Additional Information About Health Catalyst.

What is Health Catalyst's official website?

The official website for Health Catalyst is http://www.healthcatalyst.com/.

How can I contact Health Catalyst?

Health Catalyst's mailing address is 3165 E. MILLROCK SUITE 400, SALT LAKE CITY UT, 84121. The company can be reached via phone at 801-708-6800 or via email at [email protected]


MarketBeat Community Rating for Health Catalyst (NASDAQ HCAT)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  11 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  16
MarketBeat's community ratings are surveys of what our community members think about Health Catalyst and other stocks. Vote "Outperform" if you believe HCAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/25/2019 by MarketBeat.com Staff

Featured Article: What is a CD ladder?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel